Mediastinal parathyroid tumor: Giant adenoma or carcinoma?

被引:0
作者
Lorenz C. Hofbauer
Christine Spitzweg
Hans Arnholdt
Rüdiger Landgraf
Armin E. Heufelder
机构
[1] Mayo Clinic,Division of Endocrinology/Metabolism
[2] Klinikum Innenstadt,Division of Endocrinology, Medizinische Klinik
[3] Ludwig-Maximilians-University Munich,Department of Pathology
[4] Klinikum Innenstadt,Division of Endocrinology/Metabolism, Endocrine Research Unit, Joseph 5
[5] Ludwig-Maximilians-University Munich,164
[6] Mayo Clinic,undefined
来源
Endocrine Pathology | 1997年 / 8卷
关键词
p53; parathyroid adenoma; parathyroid carcinoma; primary hyperparathyroidism; retinoblastoma tumor-suppressor gene;
D O I
暂无
中图分类号
学科分类号
摘要
A 71-yr-old woman presented with progressive weakness, bone pain, polydipsia, and epigastric pain. Laboratory studies established the diagnosis of primary hyperparathyroidism with excessively elevated levels of parathyroid hormone (PTH) complicated by renal failure and anemia. Preoperative imaging using99mtechnetium hexakis 2-methoxy-isobutylisonitrile (MIBI) demonstrated an area of intense uptake in the mediastinum, which on T2-weighted magnetic resonance imaging revealed the presence of a hyper-intense mediastinal mass of 25 mm in diameter adjacent to the ascending aorta. Surgical exploration and resection of the mass were performed, and histological examination of the tumor revealed solid masses of epithelial cells growing in a trabecular pattern, hyaline bands, and low mitotic activity. Immunohistochemical staining of the tumor specimens using monoclonal mouse antihuman antibodies revealed markedly positive immunoreactivity of tumor cells for p53 protein and absence of nuclear immunoreactivity for the retinoblastoma tumor-suppressor protein, findings consistent with parathyroid carcinoma. Improved imaging techniques and advances in molecular pathology of parathyroid disorders may help to improve clinical management of patients with parathyroid neoplasia.
引用
收藏
页码:161 / 166
页数:5
相关论文
共 43 条
[1]  
Schantz A(1973)Parathyroid carcinoma Cancer 31 600-605
[2]  
Castleman B(1992)Parathyroid carcinoma: clinical presentation and pathologic features in 43 patients Medicine 71 197-205
[3]  
Wynne AG(1985)Natural history of parathyroid carcinoma Am J Surg 149 522-527
[4]  
van Heerden J(1995)Primary hyperparathyroidism: preoperative localization using technetium-sestamibi scanning J Clin Endocrinol Metab 80 7-10
[5]  
Carney JA(1993)Genetic basis of endocrine disease 5: molecular genetics of parathyroid gland neoplasia J Clin Endocrinol Metab 77 1108-1112
[6]  
Fitzpatrick LA(1994)p53 abnormalities in human parathyroid carcinoma J Clin Endocrinol Metab 78 1320-1324
[7]  
Wang C(1994)Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma N Engl J Med 330 757-761
[8]  
Gaz RD(1982)Parathyroid carcinoma: review of 62 patients Endocr Rev 3 218-226
[9]  
Mitchell BK(1993)Histopathological variables and DNA cytometry in parathyroid carcinomas Am J Surg Pathol 17 820-829
[10]  
Kinder BA(1981)Mitotic activity in benign parathyroid disease Am Soc Clin Pathol 75 345-347